Charles Ruetsch

975 total citations
59 papers, 719 citations indexed

About

Charles Ruetsch is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Charles Ruetsch has authored 59 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 16 papers in Epidemiology and 15 papers in Psychiatry and Mental health. Recurrent topics in Charles Ruetsch's work include Opioid Use Disorder Treatment (20 papers), Medication Adherence and Compliance (13 papers) and Substance Abuse Treatment and Outcomes (11 papers). Charles Ruetsch is often cited by papers focused on Opioid Use Disorder Treatment (20 papers), Medication Adherence and Compliance (13 papers) and Substance Abuse Treatment and Outcomes (11 papers). Charles Ruetsch collaborates with scholars based in United States, Belgium and Spain. Charles Ruetsch's co-authors include Joseph Tkacz, John Cacciola, Jamie B. Severt, Joseph R. Volpicelli, Erich W. Labouvie, Helen M. Pettinati, Roxanne Meyer, Kathryn Anastassopoulos, Fulton Velez and Sam Colman and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Nervous and Mental Disease and Schizophrenia Research.

In The Last Decade

Charles Ruetsch

51 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Ruetsch United States 16 344 299 107 105 96 59 719
Lídia Segura Spain 19 130 0.4× 476 1.6× 94 0.9× 254 2.4× 52 0.5× 64 915
Kari A. Stephens United States 17 227 0.7× 118 0.4× 69 0.6× 207 2.0× 47 0.5× 61 901
Caroline Salom Australia 17 158 0.5× 348 1.2× 37 0.3× 138 1.3× 70 0.7× 71 757
Mariana Cremonte Argentina 17 144 0.4× 439 1.5× 24 0.2× 234 2.2× 87 0.9× 61 785
Frances Del Boca United States 6 95 0.3× 532 1.8× 41 0.4× 303 2.9× 97 1.0× 7 758
Maria A. Parker United States 18 198 0.6× 185 0.6× 16 0.1× 82 0.8× 72 0.8× 77 848
Deric R. Kenne United States 16 196 0.6× 222 0.7× 18 0.2× 159 1.5× 107 1.1× 39 789
Donna T. Chen United States 15 592 1.7× 313 1.0× 123 1.1× 253 2.4× 194 2.0× 46 993
Pey-Jiuan Lee United States 16 133 0.4× 130 0.4× 109 1.0× 308 2.9× 81 0.8× 41 1.0k
Robin Davidson United Kingdom 9 93 0.3× 314 1.1× 59 0.6× 281 2.7× 46 0.5× 15 758

Countries citing papers authored by Charles Ruetsch

Since Specialization
Citations

This map shows the geographic impact of Charles Ruetsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Ruetsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Ruetsch more than expected).

Fields of papers citing papers by Charles Ruetsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Ruetsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Ruetsch. The network helps show where Charles Ruetsch may publish in the future.

Co-authorship network of co-authors of Charles Ruetsch

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Ruetsch. A scholar is included among the top collaborators of Charles Ruetsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Ruetsch. Charles Ruetsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
May, Dave A., Charles Ruetsch, Xin Yang, Simon D. Kyle, & Cary Fu. (2023). EPH83 Characteristics, Comorbid Gi Conditions, and Treatment Patterns Among Individuals Diagnosed with Rett Syndrome. Value in Health. 26(6). S179–S179.
3.
Forma, Felicia, et al.. (2023). Adherence to augmentation therapy for the treatment of major depressive disorder. Expert Review of Pharmacoeconomics & Outcomes Research. 23(3). 327–335. 2 indexed citations
4.
5.
Liberman, Joshua N., Sandipan Bhattacharjee, Charles Ruetsch, et al.. (2022). Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder. Health Services Research and Managerial Epidemiology. 9. 2262136376–2262136376. 5 indexed citations
6.
Liberman, Joshua N., Dawn I. Velligan, Delbert G. Robinson, et al.. (2022). Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence. SHILAP Revista de lepidopterología. 4(2). 61–70. 3 indexed citations
7.
8.
9.
Ruetsch, Charles, et al.. (2021). Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms. Neuropsychiatric Disease and Treatment. Volume 17. 3715–3726. 2 indexed citations
10.
Liberman, Joshua N., et al.. (2020). Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care. Journal of Managed Care & Specialty Pharmacy. 26(8). 987–995. 8 indexed citations
11.
Ruetsch, Charles, et al.. (2018). Claims-based proxies of patient instability among commercially insured adults with schizophrenia. ClinicoEconomics and Outcomes Research. Volume 10. 259–267. 2 indexed citations
12.
Ruetsch, Charles, et al.. (2017). Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes.. PubMed. 23(6). e172–e179. 22 indexed citations
13.
Velligan, Dawn I., William T. Carpenter, Heidi C. Waters, et al.. (2017). Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening Tool. Clinical Schizophrenia & Related Psychoses. 11(4). 224–235. 1 indexed citations
14.
Tkacz, Joseph, et al.. (2016). Relapse In Opioid Use Disorder: Implications For Health Care Utilization And Costs. Value in Health. 19(3). A188–A188. 1 indexed citations
15.
Tkacz, Joseph, et al.. (2016). The Association Between Buprenorphine Medication-Assisted Treatment Adherence And Health Care Service Utilization And Costs. Value in Health. 19(3). A187–A187. 3 indexed citations
16.
Tkacz, Joseph, et al.. (2013). Opioid analgesic-treated chronic pain patients at risk for problematic use.. PubMed. 19(11). 871–80. 12 indexed citations
17.
Ruetsch, Charles, et al.. (2012). The effect of telephonic patient support on treatment for opioid dependence: Outcomes at one year follow-up. Addictive Behaviors. 37(5). 686–689. 20 indexed citations
18.
19.
Tkacz, Joseph, et al.. (2010). Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted Treatment. Journal of Addiction Medicine. 4(4). 197–203. 20 indexed citations
20.
Pettinati, Helen M., et al.. (1996). The Natural History of Outpatient Alcohol and Drug Abuse Treatment in a Private Healthcare Setting. Alcoholism Clinical and Experimental Research. 20(5). 847–852. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lídia Segura Breakdown of academic impact, for papers by Kari A. Stephens Breakdown of academic impact, for papers by Caroline Salom Breakdown of academic impact, for papers by Mariana Cremonte Breakdown of academic impact, for papers by Frances Del Boca Breakdown of academic impact, for papers by Maria A. Parker Breakdown of academic impact, for papers by Deric R. Kenne Breakdown of academic impact, for papers by Donna T. Chen Breakdown of academic impact, for papers by Pey-Jiuan Lee Breakdown of academic impact, for papers by Robin Davidson
Rankless by CCL
2026